Longterm efficiency and safety of intravitreal injections with bevacizumab in patients with neovascularisation or macular edema
Latest Information Update: 23 Jul 2024
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinal neovascularisation; Retinal oedema
- Focus Therapeutic Use
Most Recent Events
- 20 Jul 2024 This trial has been completed (End Date: 09 Jul 2024), according to European Clinical Trials Database record.
- 20 Jul 2024 This trial has been completed (End Date: 09 Jul 2024), according to European Clinical Trials Database record.
- 19 Dec 2022 Planned number of patients changed from 500 to 800.